Clinical Trials Browser

Leukemia, Myeloid, Acute

Leukemia, Myeloid, Acute

Advanced Solid Tumors

Advanced Solid Tumors Cancer

Advanced Solid Tumor

Advanced Solid Tumour

Lung Neoplasms

Unresectable Locally Recurrent Breast Cancer

Advanced Malignant Solid Tumors

Squamous Cell Carcinoma of Head and Neck, Sarcoma

Lung Neoplasms, Ovarian Neoplasms

Advanced Gynecological Malignancies

Advanced Solid Tumor (Phase 1)

Non-Muscle Invasive Bladder Neoplasms

Advanced Lung Cancer

Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Advanced Gynecological Malignancies

Advanced Lung Cancer

Non-small Lung Cancer

Advanced Solid Tumor

Advanced Endometrial Cancer

Advanced Endometrial Cancer

Pancreatic Neoplasms

Multiple Myeloma

Metastatic Solid Tumors

CLDN18.2-positive Advanced Biliary Tract Cancer

Multiple Myeloma

Malignant Solid Tumor

Small Cell Lung Carcinoma

Advanced Extrapulmonary Neuroendocrine Cancer

Breast Neoplasms, Lung Neoplasms, Colorectal Neoplasms

Adenocarcinoma

Breast Neoplasms

Pancreatic Neoplasms

Advanced Solid Tumors

Nasopharyngeal Neoplasms, Recurrence

Locally Advanced Rectal Cancer

Colorectal Neoplasms

Pancreatic Neoplasms

Carcinoma, Hepatocellular

Resectable Esophageal Squamous Cell Carcinoma

Stomach Neoplasms

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Esophageal Squamous Cell Carcinoma

Melanoma, Sarcoma

Advanced Pancreatic Cancer

Clinical Trials

Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid Tumors

First-In-Human Study of KHN922 for Injection

Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

DEFLECT I

A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer

Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors

Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial

CYTALUX Dose Extension Study

A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors

Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection

A Prospective, Multicenter, Open-label, Single-arm Phase II Clinical Study Evaluating the Efficacy and Safety of Spatially Fractionated Radiotherapy Combined With the PraG Strategy for the Treatment of Soft Tissue Sarcoma

A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma

INJECTABL-3

Phase IIa Study of BRY812 Monotherapy in Advanced Gynecological Malignancies

A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer

A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities

A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors

Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Cancer

Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem

Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer

ELDORADO

A Study of BPR-6023021 in Advanced Solid Tumors With Bone Metastases

Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer

Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure

A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors

A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer

A Trial of MHB088C in Advanced Extrapulmonary Neuroendocrine Cancer

To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors

Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

CD73/AXL Targeted HypoSti.CAR-T Cells in CD73/AXL Positive Advanced/Metastatic Solid Tumors

Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitors

A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC

First-In-Human Study in Participants With Advanced Solid Tumors

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal Cancer

The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Injectable SPN01 in Phase I.

YL-13027 and/or HY-0102 Combined With AG Regimen Chemotherapy for Metastatic Pancreatic Cancer

CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma

Study of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal Cancer

Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric Cancer

A Clinical Trial to Evaluate the Efficacy and Safety of TQB2102 for Injection Versus Investigator-Selected Chemotherapy in HER2 Low-Expressing Recurrent/Metastatic Breast Cancer

Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion Mutations

Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC

TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors

A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer